source
- Eli Lilly’s $3.8 billion acquisition of AtaiBeckley signals strong backing for psychedelic therapeuticsNovartis and Roche kicked off the second‑quarter earnings season, with other majors such as AstraZeneca, GSK and Biogen slated to follow. The earnings wave highlights continued revenue growth acros…
- NIH joins Trump’s $5B AI Genesis Mission to boost biomedical researchThe U.S. Department of Health and Human Services announced that the National Institutes of Health will take part in the President’s Genesis Mission, a $5 billion AI-driven effort. The initiative a…